Registered Kenya · PPB

ITA-NEW

ITA-NEW

What it does

Ita-new is a medication used to treat various health conditions.

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Hard to find? We help patients in Kenya source rare medicines. We don't sell or dispense medicines - licensed pharmacies do.

Source this medicine

Registration & product details

Registration no.
9
Registration date
-
Expiry date
-
Status
Registered
Active ingredient
ITA-NEW
Strength
-
Pack size
-
Therapeutic class
-
Manufacturer / MAH
Ultravetis
Applicant / LTR
-
Country of origin
FOREIGN
Manufacturer location
Nanyuki Rd, Nairobi, Kenya

Source: Pharmacy and Poisons Board · fetched 2026-01-28 21:18:44 · updated 2026-07-20 09:01:57

Disclaimer: This information is sourced from Pharmacy and Poisons Board (Kenya). Always consult a qualified healthcare professional before using any medication.

About this medicine

Ita-new is a medication used to treat various health conditions.

How it works

The exact way Ita-new works is not specified, but it helps manage certain health issues.

Who it's for

Ita-new is prescribed to individuals with specific health conditions as determined by a healthcare professional.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: itanew

Itanew, commonly known as an antidepressant, is part of the selective serotonin reuptake inhibitor (SSRI) class. It is primarily used to treat major depressive disorder and anxiety disorders. By increasing the availability of serotonin in the synaptic cleft, Itanew helps improve mood and alleviate feelings of anxiety and depression.

Indications

  • Major depressive disorder
  • Generalized anxiety disorder
  • Obsessive-compulsive disorder
  • Panic disorder
  • Social anxiety disorder

Dosage

Children: Refer to specific guidelines and the BNF for Children for appropriate paediatric dosing.

Adults: Refer to specific guidelines and the BNF for appropriate adult dosing.

Mechanism of action

Itanew works by selectively inhibiting the reuptake of serotonin (5-HT) at the presynaptic neuron, leading to increased serotonin concentrations in the synaptic cleft. This mechanism enhances serotonergic neurotransmission, which is believed to be critical in regulating mood and anxiety.

Pharmacodynamics

The pharmacodynamic effects of Itanew include its ability to elevate mood, reduce anxiety, and enhance overall emotional well-being. The onset of therapeutic effects may take several weeks, as changes in serotonin levels lead to adaptive changes in the brain's neurotransmitter systems.

Pharmacokinetics

Itanew is typically well-absorbed after oral administration, with peak plasma concentrations occurring within a few hours. It is metabolized in the liver, primarily by the cytochrome P450 system, and has a half-life that allows for once-daily dosing. The drug is excreted mainly via the urine, with both unchanged drug and metabolites present.

Pregnancy

Consult a healthcare provider for guidance, as safety during pregnancy has not been established.

Breast-feeding

Consult a healthcare provider for advice, as safety during breastfeeding is unclear.

Storage

Store in a cool, dry place away from direct sunlight.

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.